Key takeaway
You need a way to keep someone breathing, and you are unsure whether harm reduction is treatment. A 2024 report defines it as public-health strategies. Federal grants may still pay for naloxone. They may not buy syringes or pipes. Tonight, if someone is down, call 911 and give naloxone if you have it.
Last updated: Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Someone is down, or you are afraid they will be, and you are trying to tell a public-health idea apart from a treatment plan. The emergency and the program are two different hours.
If someone will not wake, is not breathing, or is turning blue, call 911. Give naloxone if you have it and an opioid overdose is possible. Stay until help arrives. For a mental health crisis, call or text 988.
Ask what the local program still offers
A June 2024 SAMHSA report defines harm reduction as practical public-health strategies, including prevention and risk reduction, for people who use drugs and their families. The aim in that definition is a healthier life the person directs. Nearly 30 years of research on syringe services, summarized by NIDA in 2024, found that testing, counseling, and sterile supplies help prevent infectious-disease transmission without increasing crime nearby. Those programs often link people to treatment. Whether one is legal where you live is a state and local question.
An April 24, 2026 letter says SAMHSA funds may still buy naloxone and nalmefene, overdose training, and wound care. It says HHS funds may not buy syringes or needles for injecting illegal drugs, pipes or safer-smoking supplies, or drug-checking strips meant for people who are using drugs. A program paid with state, local, or private money can be a different shelf. Ask what this one actually offers. Naloxone can wear off. Nalmefene is another reversal medicine. Xylazine, covered in xylazine and fentanyl, is a sedative naloxone does not reverse. Give naloxone anyway if an opioid may be present, and stay until help arrives.
Treatment is the other door
For opioid use disorder, medication should be first-line care, usually with counseling. Those medicines are methadone, buprenorphine, and naltrexone. Do not stop methadone or buprenorphine because a supply program was easier to reach. Stopping can bring withdrawal and, later, a loss of tolerance that makes a return to use more likely to kill. More than one drug changes an overdose, which polysubstance use explains. Care for that opioid is in fentanyl treatment.
Search FindTreatment.gov for a program. Call or text (800) 653-9376 if you want help finding treatment.
Additional Resources
Sources cited on this page:
- SAMHSA: ISUDCC summary report on harm reduction (June 10, 2024)
- SAMHSA Dear Colleague letter on harm-reduction supplies and services (April 24, 2026)
- NIDA: Nora's Blog, syringe services programs (November 25, 2024)
- NIDA: Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
- SAMHSA FindTreatment.gov
- 988 Suicide & Crisis Lifeline
Common Questions
What did SAMHSA say harm reduction is?
In a report dated June 10, 2024, SAMHSA defines it as a practical approach that uses community-driven public health strategies, including prevention, risk reduction, and health promotion. The stated aim is to give people who use drugs, and their families, the choice to live healthier lives they direct. The report says the approach centers the experience of people who use drugs, especially in underserved communities. A local program may not offer every service the report names.
What does federal grant money still pay for?
An April 24, 2026 letter says SAMHSA funds may support naloxone and nalmefene, lock boxes and disposal kits, overdose education, wound-care supplies, FDA-approved home tests for hepatitis B, hepatitis C, and HIV, sharps disposal, navigation into HIV and hepatitis care, condoms, and nicotine-cessation therapies. HHS funds may not buy syringes or needles for injecting illegal drugs, pipes or safer-smoking supplies, or drug-checking strips meant for people who are using drugs. Ask the program what it actually offers.
Do syringe programs increase drug use or crime?
A November 25, 2024 NIDA summary says nearly 30 years of research show that testing, counseling, and sterile injection supplies help prevent infectious-disease transmission without increasing drug-related or other crime nearby. The evidence more often points away from the fear that these programs promote drug use. They link people to treatment and can help prevent overdose deaths. Whether a program is legal where you live is a state and local question. The 2026 letter is a separate rule about what SAMHSA grants may purchase.
Does naloxone replace 911?
No. Naloxone can restore breathing in an opioid overdose and then wear off. It does not treat a substance use disorder, and it does not reverse alcohol, a benzodiazepine, a stimulant, or xylazine. Call 911, give naloxone if an opioid may be involved, and stay. The naloxone guide is the emergency page.
Is harm reduction a substitute for treatment?
No. The 2024 report discusses linking people to care, and syringe programs often connect people with addiction treatment. Neither document says a supply program replaces an assessment, medication when it is indicated, or a level of care. If you want treatment, ask for it. If someone will not wake or is not breathing, call 911 before you look for a program.